Literature DB >> 3664038

A parallel form of the Gudjonsson Suggestibility Scale.

G H Gudjonsson1.   

Abstract

The purpose of this study is twofold: (1) to present a parallel form of the Gudjonsson Suggestibility Scale (GSS, Form 1); (2) to study test-retest reliabilities of interrogative suggestibility. Three groups of subjects were administered the two suggestibility scales in a counterbalanced order. Group 1 (28 normal subjects) and Group 2 (32 'forensic' patients) completed both scales within the same testing session, whereas Group 3 (30 'forensic' patients) completed the two scales between one week and eight months apart. All the correlations were highly significant, giving support for high 'temporal consistency' of interrogative suggestibility.

Entities:  

Mesh:

Year:  1987        PMID: 3664038     DOI: 10.1111/j.2044-8260.1987.tb01348.x

Source DB:  PubMed          Journal:  Br J Clin Psychol        ISSN: 0144-6657


  4 in total

1.  No evidence that low levels of intoxication at both encoding and retrieval impact scores on the Gudjonsson Suggestibility Scale.

Authors:  Amelia Mindthoff; Jacqueline R Evans; Nadja Schreiber Compo; Karina Polanco; Angelica V Hagsand
Journal:  Psychopharmacology (Berl)       Date:  2021-03-01       Impact factor: 4.530

2.  Interrogator intonation and memory encoding performance.

Authors:  Silvia Gubi-Kelm; Alexander F Schmidt
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

3.  Police-suspect interactions and confession rates are affected by suspects' alcohol and drug use status in low-stakes crime interrogations.

Authors:  Angelica V Hagsand; Hanna Zajac; Lovisa Lidell; Christopher E Kelly; Nadja Schreiber Compo; Jacqueline R Evans
Journal:  Front Psychol       Date:  2022-09-15

4.  Interrogative suggestibility in the elderly.

Authors:  Silvia Biondi; Cristina Mazza; Graziella Orrù; Merylin Monaro; Stefano Ferracuti; Eleonora Ricci; Alberto Di Domenico; Paolo Roma
Journal:  PLoS One       Date:  2020-11-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.